ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $72,000 | +71.4% | 20,000 | -24.5% | 0.04% | +44.4% |
Q4 2018 | $42,000 | -73.1% | 26,500 | -37.6% | 0.03% | -66.2% |
Q3 2018 | $156,000 | +69.6% | 42,500 | +30.8% | 0.08% | +63.3% |
Q2 2018 | $92,000 | -24.0% | 32,500 | -0.0% | 0.05% | -25.8% |
Q1 2018 | $121,000 | -13.6% | 32,502 | -33.0% | 0.07% | -14.3% |
Q4 2017 | $140,000 | +6.1% | 48,504 | +64.4% | 0.08% | -1.3% |
Q3 2017 | $132,000 | -16.5% | 29,500 | -14.5% | 0.08% | -21.2% |
Q2 2017 | $158,000 | +9.0% | 34,500 | 0.0% | 0.10% | +8.8% |
Q1 2017 | $145,000 | +2.1% | 34,500 | 0.0% | 0.09% | +2.2% |
Q4 2016 | $142,000 | -18.4% | 34,500 | +60.5% | 0.09% | -19.8% |
Q3 2016 | $174,000 | -26.9% | 21,500 | -29.5% | 0.11% | -27.9% |
Q2 2016 | $238,000 | +43.4% | 30,500 | +41.9% | 0.15% | +38.7% |
Q1 2016 | $166,000 | +33.9% | 21,500 | +87.0% | 0.11% | +38.8% |
Q4 2015 | $124,000 | -70.4% | 11,500 | -81.1% | 0.08% | -72.7% |
Q3 2015 | $419,000 | -47.9% | 60,700 | -33.1% | 0.29% | -39.8% |
Q2 2015 | $804,000 | +48.1% | 90,700 | +64.6% | 0.49% | +46.7% |
Q1 2015 | $543,000 | +35.4% | 55,100 | +68.5% | 0.33% | +35.5% |
Q4 2014 | $401,000 | +100.5% | 32,700 | +63.5% | 0.24% | +109.4% |
Q3 2014 | $200,000 | +102.0% | 20,000 | -33.3% | 0.12% | +88.7% |
Q1 2014 | $99,000 | – | 30,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|